Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
A Randomized, Double-Blind, Multicenter, Parallel Study Evaluating the Efficacy and Safety of a Combination of Ramipril Plus Hydrochlorothiazide Versus the Component Monotherapies in Subjects With Essential Hypertension
Study Start Date
Primary Completion Date
Study Completion Date
Resource links provided by the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Previously diagnosed, or newly diagnosed essential hypertension. Blood pressure must be within a minimum and maximum range prior to drug treatment.
Inability to discontinue all prior antihypertensive medications
History of stroke, myocardial infarction, or chest pain within 3 years, or an abnormal heart rhythm
Liver or kidney disease
Certain drugs used to treat other conditions like an enlarged prostate gland, or arthritis
Allergy or reactions to certain medications used to treat high blood pressure
Other protocol-defined inclusion and exclusion criteria apply.